Cutler Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Cutler Group’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-200	Closed	-$10K	–	5836
2020 Q3	$10K	Buy	+200	New	+$8.28K	﹤0.01%	3036
2017 Q3	–	Sell	-200	Closed	-$3.34K	–	7090
2017 Q2	$3K	Sell	200 -12,211	-98%	-$186K	﹤0.01%	5385
2017 Q1	$165K	Sell	12,411 -8,297	-40%	-$130K	0.01%	1341
2016 Q4	$311K	Buy	20,708 +2,808	+16%	+$37.1K	0.01%	1004
2016 Q3	$209K	Buy	17,900 +17,700	+8,850%	+$208K	0.01%	1170
2016 Q2	$2K	Buy	+200	New	+$2.06K	﹤0.01%	5849

Cutler Group's MNTA Position: Q4 2020 in Review

Cutler Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 200 shares — an estimated $10K sold.

Cutler Group first reported a position in MNTA in Q2 2016 and held it in 6 quarters. The position peaked at $311K in Q4 2016. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Cutler Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Cutler Group sold 200 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $10K.
Cutler Group first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2016 and held it in 6 quarters.
Cutler Group's Momenta Pharmaceuticals, Inc. position peaked at $311K in Q4 2016.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.